Data coverage, completeness and provenance for NEURIZON THERAPEUTICS LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-27T05:10:31. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0860 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0860 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0860 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0860 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0880 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/NUZ/prices · Price parameters and adjustment semantics
Neurizon Therapeutics Limited, a clinical stage biotechnology company, engages in the development of treatments for neurodegenerative diseases in Australia. Its lead candidate is NUZ-001, a small molecule drug designed to support cellular protein homeostasis which is evaluated in Regimen I of the Phase 2/3 HEALEY ALS platform trial for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Website: https://www.neurizon.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/NUZ/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 24 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 22 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 21 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 30 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 29 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/NUZ
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/NUZ/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/NUZ/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/NUZ/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/NUZ/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/NUZ
Free tier — instant API key. Built for AI agents.